Autolus Therapeutics Cash from Investing (TTM) Analysis

Autolus Therapeutics PLC (AUTL)

3.985 -0.18 (-4.44%) USD | NASDAQ | May 10, 16:00

3.985 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	-10.99M
September 30, 2023	-10.14M
June 30, 2023	-15.44M
March 31, 2023	-13.69M
December 31, 2022	-10.84M
September 30, 2022	-11.79M
June 30, 2022	-8.857M
March 31, 2022	-7.728M
December 31, 2021	-8.857M

Date	Value
September 30, 2021	-12.74M
June 30, 2021	-12.93M
March 31, 2021	-13.94M
December 31, 2020	-14.68M
September 30, 2020	-11.12M
June 30, 2020	-10.86M
March 31, 2020	-13.98M
December 31, 2019	-18.67M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-18.67M

Minimum

Dec 2019

-7.728M

Maximum

Mar 2022

-12.19M

Average

-11.79M

Median

Sep 2022

Cash from Investing (TTM) Benchmarks